News Agency of Nigeria
Iran, China launch 2nd phase of joint archaeological studies

Iran, China launch 2nd phase of joint archaeological studies

 

The second phase of the joint Iranian-Chinese archaeological investigations has officially begun at the historic village of Masouleh in northern Iran, as reported by Tehran Times, a partner of TV BRICS.

The international research effort aims to deepen understanding of ancient sponge iron smelting and to support Masouleh’s nomination for UNESCO World Heritage status.

The ongoing research also seeks to complete critical documentation for the registration of Masouleh’s cultural landscape on the World Heritage List.

The core focus of this phase is to examine the evolution and spread of sponge iron smelting technologies across historical periods and their integration into the built environment of Masouleh.

The aim is to reconstruct the historical interconnection between industrial activity and the residential fabric of Masouleh.

The research team is exploring how metallurgical zones functioned within and alongside one of Iran’s most distinctive human settlements.

The second phase of research combines targeted excavations at known metallurgical sites with rigorous cross-referencing of archaeological findings against Islamic-era travelogues, ancient geographical manuscripts, and local historical archives.

Cutting-edge scientific methods such as radiocarbon (C-14) and luminescence dating will be used to create a reliable chronological framework for Masouleh’s industrial and domestic development.

According to experts, the outcomes of this collaborative research will be instrumental in advancing Masouleh’s UNESCO nomination dossier, positioning it as a rare example of an integrated industrial-residential cultural landscape. (TV BRICS/NAN) (www.nannews.ng

Edited by Emmanuel Yashim

Iran makes great progress in bone marrow transplantation

Iran makes great progress in bone marrow transplantation

In recent years, Iranian specialists have achieved significant results in treating complex diseases such as leukaemia, myelodysplastic syndrome and lymphoma.

 

Other progress, according to ParsToday, a partner of TV BRICS, include multiple myeloma, aplastic anaemia as well as some cancers and congenital diseases through bone marrow transplantation.

A breakthrough moment was the creation by an Iranian company of an innovative cellular preparation designed for patients who have undergone bone marrow transplantation.

 

This drug significantly reduces the risk of graft-versus-host disease (GVHD), a serious complication after transplantation.

A bone marrow transplant, also known as a stem cell transplant, replaces damaged or diseased bone marrow with healthy blood-forming stem cells, often used to treat blood cancers and other conditions.

 

The primary goal is to replace unhealthy or non-functioning bone marrow with healthy stem cells that can produce new, healthy blood cells (red blood cells, white blood cells, and platelets).

According to Mostafa Ghanei, Secretary of the Biotechnology Development Headquarters, Iran is one of the leaders in the region in terms of the number and quality of bone marrow transplant operations performed.

Bone marrow transplantation has been practised in Iran for more than 30 years.

 

About 17,000 successful operations have been performed in the country, which is far ahead of other countries in the region, according to Ali Jafarian, Senior Advisor to the Minister of Health.(NAN/TV BRICS)

Edited by Ismail Abdulaziz

X
Welcome to NAN
Need help? Choose an option below and let me be your assistant.
Email SubscriptionSite SearchSend Us Email